Issue 46, 2016, Issue in Progress

A ruthenium derivative of quercetin with enhanced cholesterol-lowering activity

Abstract

A ruthenium(II) p-cymene derivative of quercetin was synthesized and functionally tested for cholesterol-lowering ability via direct 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGR) inhibition. Ruthenium complexation dramatically increased the inhibition potency of the parent quercetin toward HMGR, with a consequent enhancement of the cholesterol-lowering effect in hepatic cells.

Graphical abstract: A ruthenium derivative of quercetin with enhanced cholesterol-lowering activity

Article information

Article type
Paper
Submitted
10 Mar 2016
Accepted
13 Apr 2016
First published
14 Apr 2016

RSC Adv., 2016,6, 39636-39641

A ruthenium derivative of quercetin with enhanced cholesterol-lowering activity

M. Cuccioloni, L. Bonfili, M. Mozzicafreddo, V. Cecarini, R. Pettinari, F. Condello, C. Pettinari, F. Marchetti, M. Angeletti and A. M. Eleuteri, RSC Adv., 2016, 6, 39636 DOI: 10.1039/C6RA06403E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements